Solbu Marit D, Thomson Peter C, Macpherson Sarah, Findlay Mark D, Stevens Kathryn K, Patel Rajan K, Padmanabhan Sandosh, Jardine Alan G, Mark Patrick B
Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Section of Nephrology, University Hospital of North Norway, N-9038, Tromsø, Norway.
BMC Nephrol. 2015 Dec 1;16:194. doi: 10.1186/s12882-015-0187-1.
Hyperphosphataemia is linked to cardiovascular disease and mortality in chronic kidney disease (CKD). Outcome in CKD is also affected by socioeconomic status. The objective of this study was to assess the associations between serum phosphate, multiple deprivation and outcome in CKD patients.
All adult patients currently not on renal replacement therapy (RRT), with first time attendance to the renal outpatient clinics in the Glasgow area between July 2010 and June 2014, were included in this prospective study. Area socioeconomic status was assessed as quintiles of the Scottish Index of Multiple Deprivation (SIMD). Outcomes were all-cause and cardiovascular mortality and commencement of RRT.
The cohort included 2950 patients with a median (interquartile range) age 67.6 (53.6-76.9) years. Median (interquartile range) eGFR was 38.1 (26.3-63.5) ml/min/1.73 m(2), mean (± standard deviation) phosphate was 1.13 (± 0.24) mmol/L and 31.6 % belonged to the most deprived quintile (SIMD quintile I). During follow-up 375 patients died and 98 commenced RRT. Phosphate ≥ 1.50 mmol/L was associated with all-cause (hazard ratio (HR) 2.51; 95 % confidence interval (CI) 1.63-3.89) and cardiovascular (HR 5.05; 95 % CI 1.90-13.46) mortality when compared to phosphate 0.90-1.09 mmol/L in multivariable analyses. SIMD quintile I was independently associated with all-cause mortality. Phosphate did not weaken the association between deprivation index and mortality, and there was no interaction between phosphate and SIMD quintiles. Neither phosphate nor SIMD predicted commencement of RRT.
Multiple deprivation and serum phosphate were strong, independent predictors of all-cause mortality in CKD and showed no interaction. Phosphate also predicted cardiovascular mortality. The results suggest that phosphate lowering should be pursued regardless of socioeconomic status.
高磷血症与慢性肾脏病(CKD)患者的心血管疾病及死亡率相关。CKD的预后还受社会经济地位的影响。本研究的目的是评估CKD患者血清磷、多重贫困与预后之间的关联。
本前瞻性研究纳入了2010年7月至2014年6月期间首次到格拉斯哥地区肾脏门诊就诊、目前未接受肾脏替代治疗(RRT)的所有成年患者。地区社会经济地位根据苏格兰多重贫困指数(SIMD)的五分位数进行评估。结局指标为全因死亡率、心血管死亡率及开始接受RRT。
该队列包括2950例患者,年龄中位数(四分位间距)为67.6(53.6 - 76.9)岁。估算肾小球滤过率(eGFR)中位数(四分位间距)为38.1(26.3 - 63.5)ml/min/1.73 m²,平均(±标准差)磷水平为1.13(±0.24)mmol/L,31.6%的患者属于最贫困五分位(SIMD五分位I)。随访期间,375例患者死亡,98例开始接受RRT。在多变量分析中,与磷水平为0.90 - 1.09 mmol/L相比,磷水平≥1.50 mmol/L与全因死亡率(风险比(HR)2.51;95%置信区间(CI)1.63 - 3.89)及心血管死亡率(HR 5.05;95% CI 1.90 - 13.46)相关。SIMD五分位I与全因死亡率独立相关。磷并未削弱贫困指数与死亡率之间的关联,且磷与SIMD五分位之间无相互作用。磷和SIMD均不能预测RRT的开始。
多重贫困和血清磷是CKD患者全因死亡率的强有力独立预测因素,且无相互作用。磷还可预测心血管死亡率。结果表明,无论社会经济地位如何,都应进行降磷治疗。